Abstract
New peptide analogs of galanin corresponding to fragments of the N-terminal sequence were synthesized by an automatic solid-phase method using Fmoc-technology. Incomplete cleavage of the Boc-protection from the Trp indole ring was found during postsynthetic procedures and a method for solving this problem was proposed. Physicochemical properties of a number of natural and synthetic N-terminal fragments of galanin were been studied. A comparative evaluation of cardioprotective action of peptide agonists of the galanin GalR2 receptor was carried out on the model of the regional ischemia and reperfusion of the heart in rats in vivo. The analog that contained the carnosine sequence, H-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-βAla-His-OH, was found to most effectively protect the heart from ischemic and reperfusion stress.
Similar content being viewed by others
Notes
Reperfusion is a reestablishing of the blood flow to organs and tissues which earlier remained without the blood supply.
REFERENCES
Tatemoto, K., Rokaeus, A., Jornvall, H., McDonald, T.J., and Mutt, V., FEBS Lett., 1983, vol. 164, pp. 124–128.
Mitsukawa, K., Lu, X., and Bartfai, T., Cell. Mol. Life Sci., 2008, vol. 65, no. 12, pp. 1796–805.
Webling, K., Runesson, J., Bartfai, T., and Langel, U., Front. Endocrinol., 2012, vol. 7, no. 3, p. 146.
Wang, S., He, C., Hashemi, T., and Bayne, M., J. Biol. Chem., 1997, vol. 272, pp. 31 949–31 952.
Diaz-Cabiale, Z., Parrado, C., Vela, H., Razani, H., Covenas, R., Fuxe, K., and Narvarez, J., Neuropeptides, 2005, vol. 39, pp. 185–190.
Fang, P., Sun, J., Wang, X., Zang, Z., Bo, P., and Shi, M., Life Sci., 2013, vol. 92, pp. 628–632.
Land, T., Langel, U., Low, M., Berthold, M., Unden, A., and Bartfai, T., Int. J. Pept. Protein Res., 1991, vol. 38, pp. 267–272.
Liu, H.X., Brumovsky, P., Schmidt, R., Brown, W., Payza, K., Hodzic, L., Pou, C., Godbout, C., and Hokfelt, T., Proc. Natl. Acad. Sci. U. S. A., 2001, vol. 98, pp. 9960–9964.
Langel, U. and Bartfai, T., Ann. N.Y. Acad. Sci., 1998, vol. 863, pp. 86–93.
Lu, X., Lundström, L., Langel, Ü., and Bartfai, T., Neuropeptides, 2005, vol. 39, pp. 165–167.
Lundström, L., Lu, X., Langel, Ü., and Bartfai, T., Neuropeptides, 2005, vol. 39, pp. 169–171.
Runesson, J., Saar, I., Lundström, L., Jarv, J., and Langel, Ü., Neuropeptides, 2009, vol. 43, pp. 187–192.
Runesson, J., Galanin receptor ligands, Licentiate Thesis, Stocholm University, 2009.
Shul’zhenko, V.S., Serebryakova, L.I., Studneva, I.M., Pelogeikina, Yu.A., Veselova, O.M., Molokoedov, A.S., Ovchinnikov, M.V., Pal’keeva, M.E., Sidorova, M.V., and Pisarenko, O.I., Kardiol. Vestn., 2016, vol. 11, no. 3, pp. 12–21.
Timotin, A., Pisarenko, O., Sidorova, M., Studneva, I., Shulzhenko, V., Palkeeva, M., Serebryakova, L., Molokoedov, A., Veselova, O., Cinato, M., Tronchere, H., Boall, F., and Kunduzova, O., Oncotarget, 2017, vol. 8, no. 13, pp. 21 241–21 252.
Pisarenko, O., Timotin, A., Sidorova, M., Studneva, I., Shulzhenko, V., Palkeeva, M., Serebryakova, L., Molokoedov, A., Veselova, O., Cinato, M., Boall, F., Tronchere, H., and Kunduzova, O., Oncotarget, 2017, vol. 8, no. 60, pp. 101 659–101 671.
Webling, K., Runesson, J., Lang, A., Saar, I., Kofler, B., and Langel, Ü., Neuropeptides, 2016, vol. 60, pp. 75–82.
Korolkiewicz, R., Sliwinski, W., Recowski, P., Halama-Borowiec, A., Mucha, P., Szczurowicz, A., and Korolkiewicz, K.Z., Pharm. Res., 1997, vol. 35, no. 1, pp. 7–16.
Az’muko, A.A., Veselova, O.M., Molokoedov, A.S., Ovchinnikov, M.V., Pal’keeva, M.E., Pisarenko, O.I., Serebryakova, L.I., Sidorova, M.V., and Studneva, I.M., RF Patent no. 2 648 846, 2018, Byull. no. 10.
Vlieghe, P., Lisowski, V., Martinez, J., and Khrestchatisky, M., Drug Discov. Today, 2010, vol. 15, nos. 1/2, pp. 40–56.
Boldyrev, A., Koldobski, A., Kurella, F., Maltseva, V., and Stvolinski, S., Mol. Chem. Neuropathol., 1993, vol. 19, pp. 185–192.
Prokop’eva, V.D., Laptev, B.I., and Afanas’ev, S.A., Biokhimiya, 1992, vol. 57, pp. 1389–1392.
Arvidsson, K., Langel, U., and Ehrenberg, A., Eur. J. Biochem., 1994, vol. 222, pp. 573–581.
Iwai, K. and Ando, T., Methods Enzimol., 1967, vol. 11, pp. 263–282.
Fmoc Solid Phase Peptide Synthesis. Practical Approach, Chan, W.C. and White, P.D., Eds., New York: Oxford Univ. Press, 2004, pp. 65–67.
Mant, C., Kovacs, J., Kim, H., Pollock, D., and Hodges, R., Biopolymers, 2009, vol. 92, no. 6, pp. 573–95.
Gosudarstvennaya farmakopeya Rossiiskoi Federatsii (State Pharmacopoeia of the Russian Federation), 13th ed., Moscow, 2015. GFM 1.2.1.0005.
Knorr, R., Trzeciak, A., Bannwarth, W., and Gillessen, D., Tetrahedron Lett., 1989, vol. 30, pp. 1927–1930.
Funding
This study was supported by the Russian Foundation for Basic Research, project nos. 18-015-00008 and 18-015-00009.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interests
The authors declare that they have no conflict of interets.
Statement on the Welfare of Animals
All applicable international, national, and institutional guidelines for the care and use of animals were followed.
Additional information
Translated by L. Onoprienko
Abbreviations: Boc, tert-butyloxycarbonyl; DBU, 1,8–diazobicyclo[5.4.0]-undec-7-en; DCM, dichloromethane; DIPEA, N,N-diisopropylethylamine; DMA, N,N-dimethylacetamide; DMF, N,N-dimethylformamide; Fmoc, 9-fluorenylmethyloxycarbonyl; GalR, the galanin receptor; MALDI, the matrix-assisted laser desorption-ionization method; 4-MePip, 4-methylpiperidine; NMM, N-methylmorpholine; NMP, N-methylpyrrolidone; Pbf, 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl; TBTU, N,N,N ',N '-tetramethyl-О-(benzotriazole-1-yl)uronium tetrafluoroborate; TFA, trifluoroacetic acid; Trt, trityl; RZ, the risk zone; MI, myocardiac infarction; CК-МВ, creatine kinase МВ; VS, ventriculus sinister (left ventricle of heart); RDА, the right descending artery; SBP, systolic blood pressure; SPS, the solid phase synthesis; HR, heart rate
Corresponding author: phone: +7 (495) 414-67-16; e-mail: peptide-cardio@yandex.ru.
Rights and permissions
About this article
Cite this article
Palkeeva, M.E., Sidorova, M.V., Molokoedov, A.S. et al. Fragments of the Galanin Peptide and Their Synthetic Analogues with the Cardioprotective Effect. Russ J Bioorg Chem 45, 353–360 (2019). https://doi.org/10.1134/S1068162019040071
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162019040071